60 related articles for article (PubMed ID: 38438469)
1. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
2. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
[TBL] [Abstract][Full Text] [Related]
3. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
Ren H; Shen X; Xie M; Guo X
Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
[TBL] [Abstract][Full Text] [Related]
4. A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer.
Hong J; Li M; Chen Y; Du Y; Song D
Front Immunol; 2023; 14():1276280. PubMed ID: 38259456
[TBL] [Abstract][Full Text] [Related]
5. A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer.
Zhang P; Yang J; Zhong X; Selistre-de-Araujo HS; Boussios S; Ma Y; Fang H
Transl Cancer Res; 2024 Mar; 13(3):1554-1566. PubMed ID: 38617520
[TBL] [Abstract][Full Text] [Related]
6. A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis.
Chen W; Kang Y; Sheng W; Huang Q; Cheng J; Pei S; Meng Y
Front Immunol; 2024; 15():1331841. PubMed ID: 38370403
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
Ren X; Cui H; Dai L; Chang L; Liu D; Yan W; Zhao X; Kang H; Ma X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):119. PubMed ID: 38466449
[TBL] [Abstract][Full Text] [Related]
8. Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer.
Xu Z; Zhang L; Wang X; Pan B; Zhu M; Wang T; Xu W; Li L; Wei Y; Wu J; Zhou X
Life Sci; 2024 Jul; 349():122731. PubMed ID: 38782354
[TBL] [Abstract][Full Text] [Related]
9. Stratification and prognostic evaluation of breast cancer subtypes defined by obesity-associated genes.
Chen D; Xie Z; Yang J; Zhang T; Xiong Q; Yi C; Jiang S
Discov Oncol; 2024 Apr; 15(1):133. PubMed ID: 38676834
[TBL] [Abstract][Full Text] [Related]
10. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
Conte B; Brasó-Maristany F; Hernández AR; Pascual T; Villacampa G; Schettini F; Vidal Losada MJ; Seguí E; Angelats L; Garcia-Fructuoso I; Gómez-Bravo R; Lorman-Carbó N; Paré L; Marín-Aguilera M; Martínez-Sáez O; Adamo B; Sanfeliu E; Fratini B; Falato C; Chic N; Vivancos A; Villagrasa P; Staaf J; Parker JS; Perou CM; Prat A
EBioMedicine; 2024 Apr; 102():105043. PubMed ID: 38447275
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer.
Li S; Qian Y; Xie W; Li X; Wei J; Wang L; Ren G; Yin X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):149. PubMed ID: 38512527
[TBL] [Abstract][Full Text] [Related]
12. An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer.
Wang H; Wang R; Luo L; Hong J; Chen X; Shen K; Wang Y; Huang R; Wang Z
Front Immunol; 2023; 14():1295558. PubMed ID: 38124743
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer.
Xia H; Xu X; Guo Y; Deng X; Wang Y; Fu S
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136994
[TBL] [Abstract][Full Text] [Related]
14. Identification of immune-related prognostic biomarkers in triple-negative breast cancer.
Song XQ; Shao ZM
Transl Cancer Res; 2024 Apr; 13(4):1707-1720. PubMed ID: 38737702
[TBL] [Abstract][Full Text] [Related]
15. Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer.
Li T; Chen S; Zhang Y; Zhao Q; Ma K; Jiang X; Xiang R; Zhai F; Ling G
Funct Integr Genomics; 2023 Mar; 23(2):81. PubMed ID: 36917262
[TBL] [Abstract][Full Text] [Related]
16. Comment on "A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer".
Chehelgerdi M; Khorramian-Ghahfarokhi M; Dehkordi FB; Chehelgerdi M
BMC Cancer; 2024 Mar; 24(1):377. PubMed ID: 38528486
[TBL] [Abstract][Full Text] [Related]
17. Retraction Note: Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer.
Li T; Chen S; Zhang Y; Zhao Q; Ma K; Jiang X; Xiang R; Zhai F; Ling G
Funct Integr Genomics; 2024 May; 24(3):95. PubMed ID: 38736017
[No Abstract] [Full Text] [Related]
18. A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer.
Zhang J; Wang X; Zhang Z; Ma F; Wang F
Sci Rep; 2024 Mar; 14(1):5339. PubMed ID: 38438469
[TBL] [Abstract][Full Text] [Related]
19. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
